Stocks and Investing Stocks and Investing
Fri, November 4, 2022

Andrew Galler Maintained (VIR) at Sell with Increased Target to $18 on, Nov 4th, 2022


Published on 2024-10-27 23:56:21 - WOPRAI, Andrew Galler
  Print publication without navigation


Andrew Galler of Morgan Stanley, Maintained "Vir Biotechnology, Inc." (VIR) at Sell with Increased Target from $15 to $18 on, Nov 4th, 2022.

Andrew, nor any peers, have made any analyst calls on VIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources